GO Therapeutics
PrivateLast Round
Series A
Sep 25, 2017
Total Funding Raised
$10M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
GO Therapeutics is a biotechnology company that develops antibody-based cancer therapeutics by targeting O-linked glycoproteins specific to cancer cells for a broad array of potent cancer-killing modalities.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GO Therapeutics Comparables
Compare GO Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Combotope Therapeutics | 85% | |
| GlyTR Therapeutics | 84% | |
| Glycotope GmbH | 83% |
GO Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 25, 2017 | ||||
| Series A | Aug 16, 2017 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 160% MoM.
- Jun 20, 2026
Monthly visitors increased 169% MoM.
GO Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GO Therapeutics's valuation, stock price, and market status.
Is GO Therapeutics a public or private company?
GO Therapeutics is a private company.
What is the current stock price of GO Therapeutics?
GO Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is GO Therapeutics worth (valuation)?
Valuation information for GO Therapeutics is not publicly available.
Can I buy GO Therapeutics stock?
GO Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GO Therapeutics's last funding round?
GO Therapeutics's most recent funding round was Series A on September 25, 2017.
Who are the main investors in GO Therapeutics?
Investor information for GO Therapeutics is not publicly disclosed.
Will GO Therapeutics IPO soon?
No public IPO plans have been announced for GO Therapeutics.
How can I track GO Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GO Therapeutics's secondary market activity and sign up for updates.